Role of Montelukast in Asthma and Allergic Rhinitis Patients

• Status: Completed
• Trial end date: 2019-06-30
• Target enrollment: 0
• Participant gender: All

Summary

To determine the effect of Montelukast in Asthma and Allergic rhinits patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Clinision
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Age >18 years

• Signed Informed Consent

• Clinical diagnosis of Asthma and Allergic Rhinitis

Exclusion Criteria:

• Previous adverse reaction to Montelukast

• History of hyper-eosinophilic disorder other than atopic disease

• Female subjects who are pregnant, breast-feeding

• Any significant and active pulmonary pathology other than asthma